+42.3%
BBIO vs EPAM
-81.2%
+123.5%
-90.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | EPAM | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.1% | +3.0% | -3.0% | -0.9% |
| 7D | -3.2% | +0.7% | -4.0% | -3.4% |
| 30D | -13.6% | +17.6% | -31.2% | -17.5% |
| 3M | +7.2% | +27.1% | -19.9% | -1.2% |
| 6M | +1.5% | -17.0% | +18.4% | +5.1% |
| YTD | -5.3% | -42.4% | +37.2% | +7.7% |
| 1Y | +37.7% | -25.3% | +63.0% | +43.9% |
| 3Y | +153.9% | -55.7% | +209.7% | +198.2% |
| All | +42.3% | -81.2% | +123.5% | +59.6% |
Cumulative growth
Daily Returns
Daily percentage return beside EPAM.
Daily Out/Under-Performance
Portfolio return minus EPAM return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × EPAM return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded EPAM wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling